z-logo
open-access-imgOpen Access
Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study
Author(s) -
Braden M. Johnson,
Tony Pham,
Kate Young,
Leonidas E. Bantis,
Weijing Sun,
Anup Kasi
Publication year - 2022
Publication title -
kansas journal of medicine
Language(s) - English
Resource type - Journals
ISSN - 1948-2035
DOI - 10.17161/kjm.vol15.15975
Subject(s) - epidermal growth factor receptor , oncology , colorectal cancer , medicine , retrospective cohort study , stage (stratigraphy) , cancer research , epidermal growth factor , overall survival , cancer , receptor , biology , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom